Omnicell, Inc. (OMCL)
NASDAQ$33.22
Market Cap
$1.55B
Sector
Healthcare
Industry
Medical—Healthcare Information Services
Rank in Sector
755 of 924
Rank in Industry
30 of 40
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
OMCL Insider Trading Activity
OMCL Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $567,638 | 1 | 100 |
Related Transactions
| PARRISH MARK W | director | 0 | $0 | 1 | $567,638 | $-567,638 |
About Omnicell, Inc.
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software …
Insider Activity of Omnicell, Inc.
Over the last 12 months, insiders at Omnicell, Inc. have bought $0 and sold $567,638 worth of Omnicell, Inc. stock.
On average, over the past 5 years, insiders at Omnicell, Inc. have bought $150,479 and sold $10.14M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 4,000 shares for transaction amount of $295,040 was made by LIPPS RANDALL A (CHAIRMAN, PRESIDENT AND CEO) on 2023‑06‑08.
List of Insider Buy and Sell Transactions, Omnicell, Inc.
| 2024-12-10 | Sale | PARRISH MARK W | director | 12,000 0.026% | $47.30 | $567,638 | -9.64% | |
| 2023-06-09 | Sale | MELLON CHRISTINE MARIE | EVP, EXECUTIVE ADVISOR | 7,951 0.0179% | $73.14 | $581,568 | -52.16% | |
| 2023-06-08 | LIPPS RANDALL A | CHAIRMAN, PRESIDENT AND CEO | 4,000 0.0089% | $73.76 | $295,040 | -52.92% | ||
| 2023-03-07 | Sale | Bauer Joanne B | director | 9,797 0.0219% | $53.97 | $528,718 | +1.03% | |
| 2023-03-07 | Sale | Bauer Joanne B | director | 13,115 0.0295% | $54.24 | $711,333 | +1.03% | |
| 2022-12-27 | Sale | Seidelmann Scott Peter | EVP, CHIEF COMMERCIAL OFFICER | 945 0.0022% | $48.28 | $45,625 | +19.06% | |
| 2022-12-16 | Sale | Seidelmann Scott Peter | EVP, CHIEF COMMERCIAL OFFICER | 4,436 0.0098% | $47.79 | $211,990 | +15.16% | |
| 2022-12-01 | Sale | LIPPS RANDALL A | CHAIRMAN, PRESIDENT AND CEO | 2,500 0.0056% | $50.78 | $126,942 | +9.93% | |
| 2022-11-28 | Sale | Seidelmann Scott Peter | EVP, CHIEF COMMERCIAL OFFICER | 1,793 0.0043% | $51.46 | $92,268 | +15.20% | |
| 2022-08-26 | Sale | Kuipers Peter J. | EXECUTIVE V P& CFO | 15,481 0.0349% | $108.29 | $1.68M | -43.90% | |
| 2022-08-22 | Sale | Kuipers Peter J. | EXECUTIVE V P& CFO | 11,000 0.0246% | $105.93 | $1.17M | -42.41% | |
| 2022-08-16 | Sale | LIPPS RANDALL A | CHAIRMAN, PRESIDENT AND CEO | 13,000 0.0292% | $111.04 | $1.44M | -44.10% | |
| 2022-06-15 | Sale | Seidelmann Scott Peter | EVP, CHIEF COMMERCIAL OFFICER | 3,208 0.0071% | $110.01 | $352,912 | -42.32% | |
| 2022-03-14 | Sale | Seidelmann Scott Peter | EVP, Chief Commercial Officer | 2,525 0.0058% | $133.11 | $336,103 | -25.23% | |
| 2021-12-16 | Sale | Seidelmann Scott Peter | EVP, Chief Commercial Officer | 3,628 0.0083% | $176.90 | $641,778 | -36.55% | |
| 2021-12-16 | Sale | JOHNSTON DAN S | EVP & Chief Legal & Admin | 1,063 0.0024% | $176.88 | $188,019 | -36.55% | |
| 2021-12-08 | Sale | SPEARS JOSEPH BRIAN | Chief Accounting Officer & VP | 6,976 0.0158% | $180.76 | $1.26M | -38.34% | |
| 2021-12-07 | Sale | Kuipers Peter J. | Executive V P& CFO | 8,517 0.0196% | $181.15 | $1.54M | -37.50% | |
| 2021-12-07 | Sale | SPEARS JOSEPH BRIAN | Chief Accounting Officer & VP | 1,179 0.0027% | $181.14 | $213,564 | -37.50% | |
| 2021-11-16 | Sale | SPEARS JOSEPH BRIAN | Chief Accounting Officer & VP | 38,585 0.0879% | $180.36 | $6.96M | -36.31% |
Total: 777
*Gray background shows transactions not older than one year
Insider Historical Profitability
0.32%
| LIPPS RANDALL A | CHAIRMAN, PRESIDENT AND CEO | 318768 0.6817% | $10.59M | 2 | 173 | <0.0001% |
| WHITTERS JOSEPH E | director | 38886 0.0832% | $1.29M | 2 | 4 | +36.39% |
| Seim Robin Gene | Director | 30049 0.0643% | $998,227.78 | 1 | 54 | +11.39% |
| LINDHOLM RANDY D | director | 27763 0.0594% | $922,286.86 | 4 | 14 | <0.0001% |
| YOUNGER WILLIAM H JR | director | 20860 0.0446% | $692,969.20 | 3 | 15 | <0.0001% |
OMCL Institutional Investors: Active Positions
| Increased Positions | 158 | +61.96% | 6M | +12.61% |
| Decreased Positions | 104 | -40.78% | 5M | -11.66% |
| New Positions | 53 | New | 1M | New |
| Sold Out Positions | 31 | Sold Out | 2M | Sold Out |
| Total Postitions | 309 | +21.18% | 46M | +0.95% |
OMCL Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Blackrock, Inc. | $270,524.00 | 17.44% | 8.2M | -165,090 | -1.97% | 2024-12-31 |
| Vanguard Group Inc | $183,551.00 | 11.83% | 5.56M | +28,573 | +0.52% | 2024-12-31 |
| State Street Corp | $74,070.00 | 4.78% | 2.24M | -22,724 | -1% | 2024-12-31 |
| Dimensional Fund Advisors Lp | $54,207.00 | 3.5% | 1.64M | +394,820 | +31.64% | 2024-12-31 |
| Lazard Asset Management Llc | $54,180.00 | 3.49% | 1.64M | +737,536 | +81.56% | 2024-12-31 |
| Victory Capital Management Inc | $50,368.00 | 3.25% | 1.53M | +377,883 | +32.9% | 2024-12-31 |
| Champlain Investment Partners, Llc | $48,630.00 | 3.14% | 1.47M | -73,365 | -4.74% | 2024-12-31 |
| Sumitomo Mitsui Trust Group, Inc. | $47,864.00 | 3.09% | 1.45M | +699,925 | +93.26% | 2024-12-31 |
| Arrowmark Colorado Holdings Llc | $39,501.00 | 2.55% | 1.2M | +56,117 | +4.92% | 2024-12-31 |
| Macquarie Group Ltd | $36,780.00 | 2.37% | 1.11M | -3,941 | -0.35% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.